Trillium Therapeutics Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 22.18, while the 200-day moving average is 14.96.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 22.18 |
| 200-Day Moving Average | 14.96 |
| Average Volume (20 Days) | N/A |
Trillium Therapeutics Inc.'s most recent stock split took place on November 20, 2014 with a 30:1 split ratio.
| Last Split Date | 11/20/2014 |
| Split Ratio | 30:1 |